{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:41:55Z","timestamp":1789774915062,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>X-linked Alport syndrome (XLAS) is a congenital renal disease caused by mutations in <jats:italic>COL4A5<\/jats:italic>. In XLAS cases suspected of being caused by aberrant splicing, transcript analysis needs to be conducted to determine splicing patterns and assess the pathogenicity. However, such analysis is not always available. We conducted a functional splicing assay using a hybrid minigene for seven <jats:italic>COL4A5<\/jats:italic> intronic mutations: one was identified by us and six were found in the Human Gene Mutation Database. The minigene assay revealed exon skipping in four variants, exon skipping and a 10-bp insertion in one variant, and no change in one variant, which appeared not to be pathogenic. For one variant, our assay did not work. The results of all three cases for which transcript data were available were consistent with our assay results. Our findings may help to increase the accuracy of genetic test results and clarify the mechanisms causing aberrant splicing.<\/jats:p>","DOI":"10.1038\/s41598-019-48990-9","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:08:04Z","timestamp":1567505284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-6030","authenticated-orcid":false,"given":"Tomoko","family":"Horinouchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Minamikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3944-0110","authenticated-orcid":false,"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ishiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Aoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rini","family":"Rossanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-0088","authenticated-orcid":false,"given":"Hiroshi","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"48990_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan, C. E. Alport syndrome and thin glomerular basement membrane disease. Journal of the American Society of Nephrology: JASN 9, 1736\u20131750 (1998).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"48990_CR2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. Journal of the American Society of Nephrology: JASN 11, 649\u2013657 (2000).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"48990_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/asn.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia, M. R. et al. Genotype-phenotype correlation in X-linked Alport syndrome. Journal of the American Society of Nephrology: JASN 21, 876\u2013883, https:\/\/doi.org\/10.1681\/asn.2009070784 (2010).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"48990_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10157-015-1197-9","volume":"20","author":"XJ Fu","year":"2016","unstructured":"Fu, X. J. et al. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Clinical and experimental nephrology 20, 699\u2013702, https:\/\/doi.org\/10.1007\/s10157-015-1197-9 (2016).","journal-title":"Clinical and experimental nephrology"},{"key":"48990_CR5","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1681\/asn.2018030228","volume":"29","author":"T Horinouchi","year":"2018","unstructured":"Horinouchi, T. et al. Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome. Journal of the American Society of Nephrology: JASN 29, 2244\u20132254, https:\/\/doi.org\/10.1681\/asn.2018030228 (2018).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"48990_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2215\/cjn.04140414","volume":"9","author":"K Nozu","year":"2014","unstructured":"Nozu, K. et al. X-linked Alport syndrome caused by splicing mutations in COL4A5. Clinical journal of the American Society of Nephrology: CJASN 9, 1958\u20131964, https:\/\/doi.org\/10.2215\/cjn.04140414 (2014).","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"48990_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/embor.2009.170","volume":"10","author":"D Baralle","year":"2009","unstructured":"Baralle, D., Lucassen, A. & Buratti, E. Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO reports 10, 810\u2013816, https:\/\/doi.org\/10.1038\/embor.2009.170 (2009).","journal-title":"EMBO reports"},{"key":"48990_CR8","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.2741\/2924","volume":"13","author":"L Hartmann","year":"2008","unstructured":"Hartmann, L., Theiss, S., Niederacher, D. & Schaal, H. Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases? Frontiers in bioscience: a journal and virtual library 13, 3252\u20133272 (2008).","journal-title":"Frontiers in bioscience: a journal and virtual library"},{"key":"48990_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/humu.20765","volume":"29","author":"C Houdayer","year":"2008","unstructured":"Houdayer, C. et al. Evaluation of in silico splice tools for decision-making in molecular diagnosis. Human mutation 29, 975\u2013982, https:\/\/doi.org\/10.1002\/humu.20765 (2008).","journal-title":"Human mutation"},{"key":"48990_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00439-009-0697-7","volume":"126","author":"K Nozu","year":"2009","unstructured":"Nozu, K. et al. In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation. Human genetics 126, 533\u2013538, https:\/\/doi.org\/10.1007\/s00439-009-0697-7 (2009).","journal-title":"Human genetics"},{"issue":"12","key":"48990_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejmg.2017.08.001","volume":"60","author":"Keita Nakanishi","year":"2017","unstructured":"Nakanishi, K. et al. A comparison of splicing assays to detect an intronic variant of the OCRL gene in Lowe syndrome. European journal of medical genetics, https:\/\/doi.org\/10.1016\/j.ejmg.2017.08.001 (2017).","journal-title":"European Journal of Medical Genetics"},{"key":"48990_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0774-4","volume":"18","author":"T Yamamura","year":"2017","unstructured":"Yamamura, T. et al. An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis. BMC nephrology 18, 353, https:\/\/doi.org\/10.1186\/s12882-017-0774-4 (2017).","journal-title":"BMC nephrology"},{"key":"48990_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s10038-018-0436-9","volume":"63","author":"T Yamamura","year":"2018","unstructured":"Yamamura, T. et al. Functional splicing analysis in an infantile case of atypical hemolytic uremic syndrome caused by digenic mutations in C3 and MCP genes. Journal of human genetics 63, 755\u2013759, https:\/\/doi.org\/10.1038\/s10038-018-0436-9 (2018).","journal-title":"Journal of human genetics"},{"key":"48990_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00467-016-3565-4","volume":"32","author":"AF Malone","year":"2017","unstructured":"Malone, A. F., Funk, S. D., Alhamad, T. & Miner, J. H. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome. Pediatric nephrology (Berlin, Germany) 32, 997\u20131003, https:\/\/doi.org\/10.1007\/s00467-016-3565-4 (2017).","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"key":"48990_CR15","doi-asserted-by":"publisher","first-page":"e0178630","DOI":"10.1371\/journal.pone.0178630","volume":"12","author":"C Chiereghin","year":"2017","unstructured":"Chiereghin, C. et al. Alport syndrome cold cases: Missing mutations identified by exome sequencing and functional analysis. PloS one 12, e0178630, https:\/\/doi.org\/10.1371\/journal.pone.0178630 (2017).","journal-title":"PloS one"},{"key":"48990_CR16","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1093\/nar\/gkl498","volume":"34","author":"E Buratti","year":"2006","unstructured":"Buratti, E., Baralle, M. & Baralle, F. E. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic acids research 34, 3494\u20133510, https:\/\/doi.org\/10.1093\/nar\/gkl498 (2006).","journal-title":"Nucleic acids research"},{"key":"48990_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/humu.9349","volume":"26","author":"M Nagel","year":"2005","unstructured":"Nagel, M., Nagorka, S. & Gross, O. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Human mutation 26, 60, https:\/\/doi.org\/10.1002\/humu.9349 (2005).","journal-title":"Human mutation"},{"key":"48990_CR18","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1523-1755.2005.00204.x","volume":"67","author":"F Wang","year":"2005","unstructured":"Wang, F., Wang, Y., Ding, J. & Yang, J. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney international 67, 1268\u20131274, https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00204.x (2005).","journal-title":"Kidney international"},{"key":"48990_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","volume":"31","author":"S Weber","year":"2016","unstructured":"Weber, S. et al. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy. Pediatric nephrology (Berlin, Germany) 31, 941\u2013955, https:\/\/doi.org\/10.1007\/s00467-015-3302-4 (2016).","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"key":"48990_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00439-002-0830-3","volume":"111","author":"K King","year":"2002","unstructured":"King, K., Flinter, F. A., Nihalani, V. & Green, P. M. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome. Human genetics 111, 548\u2013554, https:\/\/doi.org\/10.1007\/s00439-002-0830-3 (2002).","journal-title":"Human genetics"},{"key":"48990_CR21","doi-asserted-by":"publisher","unstructured":"Martin, P. et al. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients. Human mutation 15, 579, https:\/\/doi.org\/10.1002\/1098-1004(200006)15:6<579::Aid-humu13>3.0.Co;2-k (2000).","DOI":"10.1002\/1098-1004"},{"key":"48990_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrg2164","volume":"8","author":"GS Wang","year":"2007","unstructured":"Wang, G. S. & Cooper, T. A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nature reviews. Genetics 8, 749\u2013761, https:\/\/doi.org\/10.1038\/nrg2164 (2007).","journal-title":"Nature reviews. Genetics"},{"key":"48990_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1172\/jci19547","volume":"112","author":"P Sazani","year":"2003","unstructured":"Sazani, P. & Kole, R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. The Journal of clinical investigation 112, 481\u2013486, https:\/\/doi.org\/10.1172\/jci19547 (2003).","journal-title":"The Journal of clinical investigation"},{"key":"48990_CR24","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2146\/news160063","volume":"73","author":"K Traynor","year":"2016","unstructured":"Traynor, K. Eteplirsen approved for Duchenne muscular dystrophy. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 73, 1719, https:\/\/doi.org\/10.2146\/news160063 (2016).","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"key":"48990_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","volume":"8","author":"EW Ottesen","year":"2017","unstructured":"Ottesen, E. W. ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy. Translational neuroscience 8, 1\u20136, https:\/\/doi.org\/10.1515\/tnsci-2017-0001 (2017).","journal-title":"Translational neuroscience"},{"key":"48990_CR26","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura, Y. et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney international 85, 1208\u20131213, https:\/\/doi.org\/10.1038\/ki.2013.479 (2014).","journal-title":"Kidney international"},{"key":"48990_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ki.1994.413","volume":"46","author":"K Nakanishi","year":"1994","unstructured":"Nakanishi, K. et al. Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis. Kidney international 46, 1413\u20131421 (1994).","journal-title":"Kidney international"},{"issue":"2","key":"48990_CR28","doi-asserted-by":"publisher","first-page":"257.e1-257.e14","DOI":"10.1053\/j.ajkd.2007.05.004","volume":"50","author":"B\u00e1rbara Taz\u00f3n-Vega","year":"2007","unstructured":"Tazon-Vega, B. et al. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples. American journal of kidney diseases: the official journal of the National Kidney Foundation 50, 257.e251\u2013214, https:\/\/doi.org\/10.1053\/j.ajkd.2007.05.004 (2007).","journal-title":"American Journal of Kidney Diseases"},{"key":"48990_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/humu.23364","volume":"39","author":"S Daga","year":"2018","unstructured":"Daga, S. et al. Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome. Human mutation 39, 302\u2013314, https:\/\/doi.org\/10.1002\/humu.23364 (2018).","journal-title":"Human mutation"},{"key":"48990_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cell.2007.10.041","volume":"131","author":"MK Doma","year":"2007","unstructured":"Doma, M. K. & Parker, R. RNA quality control in eukaryotes. Cell 131, 660\u2013668, https:\/\/doi.org\/10.1016\/j.cell.2007.10.041 (2007).","journal-title":"Cell"},{"key":"48990_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/humu.20796","volume":"29","author":"I Tournier","year":"2008","unstructured":"Tournier, I. et al. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Human mutation 29, 1412\u20131424, https:\/\/doi.org\/10.1002\/humu.20796 (2008).","journal-title":"Human mutation"},{"key":"48990_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mgg3.145","volume":"3","author":"HM van der Klift","year":"2015","unstructured":"van der Klift, H. M. et al. Splicing analysis for exonic and intronic mismatch repair gene variants associated with Lynch syndrome confirms high concordance between minigene assays and patient RNA analyses. Molecular genetics & genomic medicine 3, 327\u2013345, https:\/\/doi.org\/10.1002\/mgg3.145 (2015).","journal-title":"Molecular genetics & genomic medicine"},{"key":"48990_CR33","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet, F. O. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic acids research 37, e67, https:\/\/doi.org\/10.1093\/nar\/gkp215 (2009).","journal-title":"Nucleic acids research"},{"key":"48990_CR34","doi-asserted-by":"publisher","first-page":"e1001016","DOI":"10.1371\/journal.pcbi.1001016","volume":"6","author":"A Corvelo","year":"2010","unstructured":"Corvelo, A., Hallegger, M., Smith, C. W. & Eyras, E. Genome-wide association between branch point properties and alternative splicing. PLoS computational biology 6, e1001016, https:\/\/doi.org\/10.1371\/journal.pcbi.1001016 (2010).","journal-title":"PLoS computational biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48990-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48990-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48990-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:15:12Z","timestamp":1671282912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48990-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48990"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48990-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12696"}}